|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
SCIDIR_ocn999607309 |
003 |
OCoLC |
005 |
20231120010211.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
170427s2017 xx fo 000 0 eng d |
040 |
|
|
|a NLE
|b eng
|e rda
|e pn
|c NLE
|d UPM
|d OCLCQ
|d YDX
|d OCLCF
|d OPELS
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1055313622
|
020 |
|
|
|a 9780128122273
|q (EPUB)
|
020 |
|
|
|a 0128122277
|q (EPUB)
|
020 |
|
|
|z 9780128122266
|
020 |
|
|
|z 0128122269
|
035 |
|
|
|a (OCoLC)999607309
|z (OCoLC)1055313622
|
050 |
|
4 |
|a RM300
|b .P76 2017
|
082 |
0 |
4 |
|a 615.1
|
245 |
0 |
0 |
|a Profiles of Drug Substances, Excipients, and Related Methodology /
|c Harry G. Brittain.
|
264 |
|
1 |
|b Academic Press,
|c 2017.
|
300 |
|
|
|a 1 online resource (424 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Profiles of drug substances, excipients, and related methodology ;
|v 42
|
490 |
0 |
|
|a Profiles of Drug Substances, Excipients and Related Methodology ;
|v 42
|
500 |
|
|
|a 1. Cinacalcet 2. Clenbuterol 3. Gliclazide 4. Lomefloxacin 5. Olmesartan 6. Propranolol 7. Tolterodine Tartrate 8. Infrared Spectroscopy of Pharmaceutical Substances in the Solid State.
|
505 |
0 |
|
|a Title page; Table of Contents; Copyright; Contributors; Preface to Volume 42; Chapter One: Cinacalcet Hydrochloride; Abstract; 1 Description; 2 Uses and Applications; 3 Methods of Preparation; 4 Physical Characteristics; 5 Methods of Analysis; 6 Stability; 7 Metabolism; 8 Pharmacokinetics and Pharmacodynamics; Acknowledgments; Chapter Two: Clenbuterol Hydrochloride; Abstract; 1 Description; 2 Methods of Preparation; 3 Physical Characteristics; 4 Methods of Analysis; 5 Stability; 6 Pharmacokinetics, Metabolism, and Excretion; 7 Pharmacology; Chapter Three: Gliclazide; Abstract; 1 Description.
|
505 |
8 |
|
|a 2 Methods of Preparation3 Physical Characteristics; 4 Methods of Analysis; 5 Biological Analysis; 6 Stability; 7 Pharmacokinetics; 8 Pharmacology; 9 Adverse Effects; 10 Drug Interactions; 11 Toxicology; Acknowledgment; Chapter Four: Lomefloxacin; Abstract; 1 Physical Profile of Lomefloxacin; 2 Analytical Profile of Lomefloxacin; 3 ADME Profiles of Drug Substances and Excipients; 4 Methodology Related to the Characterization of Lomefloxacin; 5 Methods of Chemical Synthesis; Acknowledgments; Chapter Five: Olmesartan; Abstract; 1 Description; 2 Synthesis; 3 Physical Characteristics.
|
505 |
8 |
|
|a 4 Methods of Analysis5 Stability; 6 Clinical Applications; Chapter Six: Propranolol; Abstract; 1 Description; 2 Methods of Preparation; 3 Physical Characteristics; 4 Methods of Analysis; 5 Stability; 6 Pharmacokinetics, Metabolism, and Excretion; 7 Pharmacology; Chapter Seven: Tolterodine Tartrate; Abstract; 1 General Information; 2 Physical Profile; 3 Methods of Chemical Synthesis; 4 Stability; 5 Analytical Profile; 6 ADME Profile; Acknowledgments; Index.
|
520 |
|
|
|a Profiles of Drug Substances, Excipients, and Related Methodology, Volume 42 presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients, thus meeting the needs of the pharmaceutical community and allowing for the development of a timely vehicle for publishing review materials on the topic. This latest release covers a variety of substances, including Cinacalcet Hydrochloride, Clenbuterol Hydrochloride, Gliclazide, Lomefloxacin, Olmesartan, Propranolol, and Tolterodine Tartrate. The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories, Physical profiles of drug substances and excipients, Analytical profiles of drug substances and excipients, Drug metabolism and pharmacokinetic profiles of drug substances and excipients, Methodology related to the characterization of drug substances and excipients, Methods of chemical synthesis, and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients.
|
650 |
|
0 |
|a Drugs.
|
650 |
|
2 |
|a Pharmaceutical Preparations
|0 (DNLM)D004364
|
650 |
|
6 |
|a M�edicaments.
|0 (CaQQLa)201-0002990
|
650 |
|
7 |
|a Drugs
|2 fast
|0 (OCoLC)fst00898761
|
700 |
1 |
|
|a Brittain, Harry G.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|a Brittain, Harry G.
|t Profiles of Drug Substances, Excipients, and Related Methodology.
|d Saint Louis : Elsevier Science, �2017
|z 9780128122266
|
830 |
|
0 |
|a Profiles of drug substances, excipients, and related methodology ;
|v v. 42.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/18715125/42
|z Texto completo
|